--- title: "NEXGEL, Inc. (NXGL.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/NXGL.US.md" symbol: "NXGL.US" name: "NEXGEL, Inc." industry: "Health Care Supplies" --- # NEXGEL, Inc. (NXGL.US) | Item | Detail | |------|--------| | Industry | Health Care Supplies | | Location | US Market | | Website | [nexgel.com](https://nexgel.com) | ## Company Profile NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over... ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-14T04:30:13.000Z **Overall: C (0.42)** **Industry**: Health Care Supplies | Metric | Value | |--------|-------| | Industry Ranking | 30 / 43 | | Industry Median | C | | Industry Average | C | - **Style**: Blend - Stocks in which the company has both growth and mature businesses. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 73.37% | | | Net Profit YoY | 18.39% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | 2.04 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 10.59M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 11.67M | | **Multi Score**: C #### Profit Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | -58.34% | E | | Profit Margin | -24.69% | E | | Gross Margin | 42.37% | B | #### Growth Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | 73.37% | A | | Net Profit YoY | 18.39% | B | | Total Assets YoY | 9.91% | B | | Net Assets YoY | 11.83% | B | #### Cash Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -405.07% | D | | OCF YoY | 73.37% | A | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.05 | A | #### Debt Score: C | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 52.01% | C | ```chart-data:radar { "title": "Longbridge Financial Score - NEXGEL, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "D", "indicators": [ { "name": "ROE", "value": "-58.34%", "rating": "E" }, { "name": "Profit Margin", "value": "-24.69%", "rating": "E" }, { "name": "Gross Margin", "value": "42.37%", "rating": "B" } ] }, { "name": "Growth", "grade": "A", "indicators": [ { "name": "Revenue YoY", "value": "73.37%", "rating": "A" }, { "name": "Net Profit YoY", "value": "18.39%", "rating": "B" }, { "name": "Total Assets YoY", "value": "9.91%", "rating": "B" }, { "name": "Net Assets YoY", "value": "11.83%", "rating": "B" } ] }, { "name": "Cash", "grade": "C", "indicators": [ { "name": "Cash Flow Margin", "value": "-405.07%", "rating": "D" }, { "name": "OCF YoY", "value": "73.37%", "rating": "A" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.05", "rating": "A" } ] }, { "name": "Security", "grade": "C", "indicators": [ { "name": "Gearing Ratio", "value": "52.01%", "rating": "C" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | Essilor (US.ESLOY) | B | B | C | B | B | B | | 02 | HOYA Corporation (US.HOCPY) | A | B | B | A | C | B | | 03 | Align (US.ALGN) | B | C | B | B | C | B | | 04 | Merit Medical (US.MMSI) | B | B | B | C | B | B | | 05 | UFP Tech (US.UFPT) | B | B | A | B | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -3.68 | 29/44 | - | - | - | | PB | 2.04 | 22/44 | 4.27 | 3.67 | 2.73 | | PS (TTM) | 0.91 | 10/44 | 2.29 | 1.74 | 1.21 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2025-11-12T05:00:00.000Z Total Analysts: **1** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 0 | 0% | | Overweight | 1 | 100% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 1.30 | | Highest Target | 6.00 | | Lowest Target | 6.00 | ## References - [Company Overview](https://longbridge.com/en/quote/NXGL.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/NXGL.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/NXGL.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.